He's back: Ex-GM wins CEO role

Prescient Therapeutics has landed high-flyer James McDonnell to head the company, with McDonnell stepping into the CEO role on 20 January next year.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here